Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Non-Hodgkin-Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02219737
What this trial is testing

Ibrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
CD20 PositiveRecurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)WithdrawnNCT04535102
What this trial is testing

POLA+BR for Relapsed or Refractory DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
University of Colorado, Denver
Testing effectiveness (Phase 2)Study completedNCT00006251
What this trial is testing

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more
Fred Hutchinson Cancer Center 21
Testing effectiveness (Phase 2)Ended earlyNCT04161118
What this trial is testing

TisaGenlecleucel in Elderly Patients With First-Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin Lymphoma

Who this might be right for
Non Hodgkin Lymphoma
University of Cologne 3
Not applicableUnknownNCT02667366
What this trial is testing

Effectiveness and Cost-effectiveness of Telephone-delivered Psychotherapy for Depression in Primary Care

Who this might be right for
Depression
University of Zurich 56
Not applicableEnded earlyNCT00000723
What this trial is testing

The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer

Who this might be right for
Lymphoma, Non-HodgkinHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more
National Cancer Institute (NCI) 1,377
Testing effectiveness (Phase 2)Study completedNCT00003061
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma

Who this might be right for
Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC 50
Large-scale testing (Phase 3)Study completedNCT00799461
What this trial is testing

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Early research (Phase 1)Study completedNCT00077155
What this trial is testing

Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
AIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+52 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Ended earlyNCT03075553
What this trial is testing

Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Who this might be right for
Blastic Plasmacytoid Dendritic Cell NeoplasmHepatosplenic T-Cell LymphomaHTLV-1 Infection+14 more
Mayo Clinic 12
Early research (Phase 1)Study completedNCT03886831
What this trial is testing

PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies

Who this might be right for
Relapsed/Refractory Advanced Solid TumorsRelapsed/Refractory Diffuse Large B-cell LymphomaRelapsed/Refractory Myelodysplasia+5 more
Prelude Therapeutics Incorporated 232
Testing effectiveness (Phase 2)Study completedNCT03484702
What this trial is testing

Trial to Determine the Efficacy and Safety of JCAR017 in Adult Participants With Aggressive B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Celgene 113
Early research (Phase 1)Study completedNCT02631044
What this trial is testing

Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)

Who this might be right for
Non-Hodgkin LymphomaDiffuse Large B Cell LymphomaFollicular Lymphoma+2 more
Juno Therapeutics, a Subsidiary of Celgene 387
Early research (Phase 1)Study completedNCT05359211
What this trial is testing

NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Grade 3b Follicular Lymphoma+6 more
Fred Hutchinson Cancer Center 27
Not applicableStudy completedNCT00049465
What this trial is testing

Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00089011
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more
Fred Hutchinson Cancer Center 150
Testing effectiveness (Phase 2)WithdrawnNCT00387530
What this trial is testing

Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer

Who this might be right for
Gastric CancerHead and Neck CancerLymphoma+1 more
University of California, San Diego
Not applicableStudy completedNCT05972577
What this trial is testing

Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAplastic Anemia+9 more
Ohio State University Comprehensive Cancer Center 30
Early research (Phase 1)Ended earlyNCT00800150
What this trial is testing

Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
City of Hope Medical Center 6
Next Page